局限性侵袭性牙周炎治疗改变局部宿主免疫炎症谱:长期评估
结果显示治疗后除可见菌斑外临床指标均改善,IL-12p70、IL-2、IL-6、MIP-1α、RANKL和OPG水平降低,判别分析显示病变与健康位点的免疫炎症谱差异缩小。结论认为牙周治疗长期改变了局部免疫炎症谱并伴临床稳定。
要点
- 机械清创联合全身阿莫西林/甲硝唑7天可长期改善局限性侵袭性牙周炎临床指标。
- 治疗后IL-12p70、IL-2、IL-6、MIP-1α、RANKL和OPG水平降低。
- 病变与健康位点间的免疫炎症谱差异在治疗后缩小。
核心结论
- 牙周治疗长期改变了局限性侵袭性牙周炎位点的局部免疫炎症谱,表现为标志物较基线变化并伴临床稳定。
研究设计与样本
- 在基线及治疗后3、6、12、24个月从病变和健康位点采集龈沟液,用Milliplex®检测16种炎症/骨吸收标志物。
- 进行单变量和相关性分析,并用判别分析比较各时间点病变与健康位点谱差异相对于基线的变化。
主要发现
- 与基线相比,所有时间点临床参数(除可见菌斑外)均观察到降低。
- 治疗后IL-12p70、IL-2、IL-6、MIP-1α、RANKL和OPG水平降低,且多种细胞因子/趋化因子与临床参数降低相关。
- 判别分析显示,与基线相比,治疗后病变与健康位点间的免疫炎症谱差异减小。
临床怎么用
- 对局限性侵袭性牙周炎患者,机械清创联合全身阿莫西林/甲硝唑7天可长期改善临床指标并调节局部免疫炎症标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To evaluate the local immunoinflammatory profiles in localized aggressive periodontitis patients (LAP) before and after periodontal treatment and maintenance. METHODS: Sixty-six African-Americans with LAP (7-21 years old) were included. After periodontal examination, all patients received periodontal treatment with mechanical debridement plus systemic amoxicillin/metronidazole for 7 days. Gingival crevicular fluid was collected from diseased and healthy sites at baseline and 3, 6, 12, and 24 months following treatment. Levels of 16 inflammatory/bone resorption markers were determined using Milliplex® . Univariate and correlation analyses were performed among all parameters/biomarkers. Discriminant analyses (DA) evaluated profile differences between LAP diseased and healthy sites at each time point as compared to the baseline. RESULTS: Reductions in the clinical parameters (except for visible plaque) were observed at all time points compared to the baseline. Levels of IL-12p70, IL-2, IL-6, MIP-1α, RANKL, and OPG were reduced after treatment, and several cytokines/chemokines were correlated with clinical parameters reductions. DA showed that differences in the immunoinflammatory profiles between LAP diseased and healthy sites decreased after periodontal treatment compared to the baseline. CONCLUSIONS: Periodontal treatment modified the local immunoinflammatory profile of LAP sites in the long term, as suggested by changes in biomarkers from baseline, along with clinical stability of the disease. (Clinicaltrials.gov number, NCT01330719).
引用
- Branco-de-Almeida LS, Cruz-Almeida Y, Gonzalez-Marrero Y, et al. Treatment of localized aggressive periodontitis alters local host immunoinflammatory profiles: A long-term evaluation. J Clin Periodontol. 2020. PMID: 33205510. doi:10.1111/jcpe.13404
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。